Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Int J Stroke. 2015 Mar 22;10(4):494–500. doi: 10.1111/ijs.12476

Figure 1.

Figure 1

Results of chi-square analysis of symptomatic (upper panel) and asymptomatic (lower panel) intracranial hemorrhage by treatment (ALB, saline) in the 4 categories of thrombolytic interventions employed in the ALIAS Part 2 Trial (IV tPA plus endovascular therapy; IV tPA without endovascular; endovascular without IV tPA; and neither therapy). The fractions shown represent (number of observed cases)/(number of expected cases based upon the proportion of the respective thrombolytic category within the entire sample). Observed numbers of symptomatic ICH (sICH) cases significantly exceed expected numbers in subjects receiving endovascular therapies together with ALB. (See text for statistical details.)